| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |